%0 Journal Article
%T Effects of Evolocumab on the ApoA1 Remnant Ratio: A Pooled Analysis of Phase 3 Studies
%A Blai Coll
%A Heidi T. May
%A J. Antonio G. L¨®pez
%A John Nelson
%A Joseph B. Muhlestein
%A Yuhui Ma
%J Archive of "Cardiology and Therapy".
%D 2019
%R 10.1007/s40119-019-0133-6
%X The online version of this article (10.1007/s40119-019-0133-6) contains supplementary material, which is available to authorized users
%K Evolocumab
%K Mixed dyslipidemia
%K Non-HDL-C
%K PCSK9
%K Remnant lipoprotein
%K Threshold
%K VLDL
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525215/